[Not Available].
作者信息
Morgan Steven G, Herder Matthew
机构信息
School of Population and Public Health (Morgan), University of British Columbia, Vancouver, C.-B.; Health Law Institute (Herder), Schulich School of Law, et Département de pharmacologie (Herder), Faculté de médecine, Dalhousie University, Halifax, N.-É.
出版信息
CMAJ. 2024 Oct 6;196(33):E1157-E1159. doi: 10.1503/cmaj.240935-f.
Abstract
摘要
相似文献
1
[Not Available].[无可用内容]
CMAJ. 2024 Oct 6;196(33):E1157-E1159. doi: 10.1503/cmaj.240935-f.
本文引用的文献
1
Resignations at Canada's drug pricing panel raise independence questions.加拿大药品定价委员会的人员辞职引发了对其独立性的质疑。
CMAJ. 2023 Mar 14;195(10):E378-E379. doi: 10.1503/cmaj.1096044.
2
On Measuring the Inequity of Financing Health Care in the United States and the Redistribution of Income Through Health Care Financing in Canada.论美国医疗保健融资的不公平性以及加拿大通过医疗保健融资进行的收入再分配。
Am J Public Health. 2020 Nov;110(11):1603-1604. doi: 10.2105/AJPH.2020.305891.
3
Prescription drug coverage in Canada: a review of the economic, policy and political considerations for universal pharmacare.加拿大的处方药保险范围：对全民药物保险的经济、政策和政治考量的综述
J Pharm Policy Pract. 2018 Nov 7;11:28. doi: 10.1186/s40545-018-0154-x. eCollection 2018.
4
Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.加拿大不列颠哥伦比亚省从基于年龄的处方药保险向基于收入的处方药保险过渡的分配后果。
Health Econ. 2008 Dec;17(12):1379-92. doi: 10.1002/hec.1337.
Zotero 插件